Proprietary & Confidential—This material is proprietary to My Life Spark P.C. Unauthorized use, reproduction, or distribution is strictly prohibited.

Life Spark Survivorship Institute
GLP-1 series

Module 3 · Evidence · cost · coverage

Obesity, Cardiometabolic Health & GLP-1 Therapies

How the agents work, SURMOUNT-5 head-to-head weight loss, SELECT cardiovascular benefit, safety, cost, coverage, and adherence.

14 slides · 18 minutes

Download the slidesAll modules

What this module covers

  1. 01What GLP-1 therapies are and how they work
  2. 02The major medications, mapped
  3. 03SURMOUNT-5: head-to-head weight loss
  4. 04SELECT: proven heart benefit
  5. 05Beyond weight: cardiometabolic gains
  6. 06Safety profile and monitoring
  7. 07One drug, very different prices
  8. 08Who pays, and for what
  9. 09Adherence and discontinuation

Key takeaways

Semaglutide has proven cardiovascular outcome benefit.

Price and coverage, not efficacy, decide who stays on therapy.

Cardiometabolic gains extend well beyond the scale.

Continue the series

Module 1

GLP-1–Based Therapies in Cardio-Oncology

Module 2

GLP-1 Receptor Agonist Therapy: The Complete Briefing

Module 4

Managing Adverse Effects & Safety Considerations

Educational information only. It does not replace advice from your oncology or primary care team, and no treatment decision should be made from this module alone.